BECTON, DICKINSON AND COMPANY Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
BECTON, DICKINSON AND COMPANY (BDX) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $16.00 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2025 was $16.00M, a 75.00% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $64.00M, a 966.67% increase from fiscal 2023.
- BECTON, DICKINSON AND COMPANY unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $6.00M, a 92.21% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $77.00M, a 57.92% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2025-09-30 | $16.00M 10-K · filed 2025-11-25 |
| 2024-09-30 | $64.00M 10-K · filed 2025-11-25 |
| 2023-09-30 | $6.00M 10-K · filed 2025-11-25 |
| 2022-09-30 | $77.00M 10-K · filed 2024-11-27 |
| 2021-09-30 | $183.00M 10-K · filed 2023-11-21 |
| 2020-09-30 | $4.00M 10-K · filed 2022-11-22 |
| 2019-09-30 | $0.00 10-K · filed 2021-11-24 |
| 2018-09-30 | $29.00M 10-K · filed 2020-11-25 |
| 2017-09-30 | $145.00M 10-K · filed 2019-11-27 |
| 2016-09-30 | $147.00M 10-K · filed 2018-11-21 |
| 2015-09-30 | $10.00M 10-K · filed 2017-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |